Cited by 22Diabetes Management and EducationMedication Adherence and ComplianceDiabetes Treatment and Management

A tailored cognitive-behavioural intervention produces comparable reductions in regimen-related distress in adults with type 2 diabetes regardless of insulin use: 12-month outcomes from the COMRADE trial

Lutes, Lesley D., Cummings, Doyle M., Littlewood, Kerry, Le, Marina T., Kirian, Kari, Patil, Shivajirao, Solar, Chelsey, Carraway, Marissa +1 more·2020·Canadian Journal of Diabetes

Abstract

Objectives Our aim in this study was to determine whether a cognitive-behavioural therapy plus small changes lifestyle intervention can produce comparable improvements in insulin users vs patients not using insulin with uncontrolled type 2 diabetes (T2D) and comorbid depressive or regimen-related distress (RRD) symptoms.Methods This study is a secondary analysis of Collaborative Care Management for Distress and Depression in Rural Diabetes Study, a randomized, controlled trial of a 16-session, severity-tailored cognitive-behavioural therapy plus small changes lifestyle intervention compared with usual care. Outcomes included glycated hemoglobin (A1C), regimen-related distress, depression, medication adherence and diabetes self-care. Our investigation provides 2 sets of contrasts: 1) insulin users in the intervention group compared with insulin users in the usual-care group and 2) insulin users compared with noninsulin users in the intervention group only.Results Of the 139 participants, 72 (52%) were using insulin at baseline and had significantly higher levels of A1C (10.2±2.1% vs 8.9±1.6%) and RRD (3.3±1.4 vs 2.8±1.1), and significantly poorer medication adherence (5.2±2.1 days/wk vs 5.5±1.7 days/wk). Intervention patients using insulin exhibited significantly greater reductions in RRD and marginally significant improvements in medication adherence and A1C compared with insulin users in usual care. Within the intervention group, changes in RRD, medication adherence and A1C did not differ significantly by insulin use.Conclusions Tailored cognitive-behavioural therapy with a small-changes lifestyle intervention improved elevated RRD and A1C outcomes at least as effectively in insulin users as non‒insulin users. Future powered studies need to address the role of insulin use in uptake and treatment outcomes.

Integrity signals

Registry

Crossref · 10.1016/j.jcjd.2020.05.016

Cites

30 of 30 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

1 of the 31 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Lutes, L. D., Cummings, D. M., Littlewood, K., Le, M. T., Kirian, K., Patil, S., Solar, C., Carraway, M., & Hambidge, B.
Affiliations
  • University of British Columbia (CA)
  • East Carolina University (US)
  • University of South Florida (US)
Corresponding author
Lutes, Lesley D.
Venue
Canadian Journal of Diabetes
Publisher
Elsevier BV
Published
2020-08
Volume
44
Issue
6
Pages
530-536
ISSN
1499-2671 (ISSN-L)
OpenAlex
W3035369488
Cited by
22
References
31
Citations by year
2026: 3 · 2025: 6 · 2024: 6 · 2023: 4 · 2022: 3
FWCI
1.32
Type
journal article
Language
en
Open access
closed
Locations
  • Canadian Journal of Diabetes (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • East Carolina University
  • Bristol-Myers Squibb Foundation
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
  • Health Sciences › Medicine › Family Practice › Medication Adherence and Compliance
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
Keywords
type 2 diabetes, regimen-related distress, cognitive behavioral therapy, insulin use, medication adherence, HbA1c, depression, diabetes self-care, personalized interventions
MeSH terms
Blood Glucose, Cognition Disorders, Depression, Diabetes Mellitus, Type 2, Female, Follow-Up Studies, Glycated Hemoglobin, Humans, Hypoglycemic Agents, Insulin, Life Style, Male, Middle Aged, Prognosis, Self Care, Biomarkers, Cognitive Behavioral Therapy, Medication Adherence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review